Search

Canadian Urban Data Catalogue Logo
Summary Safety Review - Dipeptidylpeptidase-4 (DPP-4) Inhibitors - Assessing the Potential Risk of Heart Failure
Health Canada
Health Canada — 2017-06-15 A safety review was carried out by Health Canada to evaluate the increased risk of heart failure with the use of DPP-4 inhibitors as a follow-up to a risk communication released by the U.S. FDA stating that saxagliptin and alogliptin might increase the risk of heart failure, in particular in patients who have other risk factors for heart failure. The product safety information in the U.S. and Canada were recently updated to include this risk. https://open.canada.ca/en/open-government-licence-canada
Canadian Urban Data Catalogue Logo
Prohibitions related to Surrogacy
Health Canada
Health Canada — 2017-05-18 Under section 6 of the AHR Act, no person shall pay, offer to pay or advertise that they will pay a woman to be a surrogate mother. https://open.canada.ca/en/open-government-licence-canada
Canadian Urban Data Catalogue Logo
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document – Chlorine
Health Canada
Health Canada — 2017-01-22 This Guideline Technical Document focuses on the health effects related to exposure to chlorine in drinking water supplies. It does not review the benefits or the processes of chlorination, nor does it assess the health risks related to exposure to by-products formed as a result of the chlorination process. https://open.canada.ca/en/open-government-licence-canada
Canadian Urban Data Catalogue Logo
Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation
Health Canada
Health Canada — 2023-01-11 The time to complete the screening of a drug submission with a rolling review is 25 days. Once the screening acceptance letter is issued, the review 1 period would begin. The submission would immediately be placed on “rolling review” until Health Canada receives all of the missing information, as indicated in the notice. https://open.canada.ca/en/open-government-licence-canada
Canadian Urban Data Catalogue Logo
Infographic: Ventilation and indoor air quality
Health Canada
Health Canada — 2021-04-13 Ventilation is the movement of air into or out of homes. It can be used to improve indoor air quality by removing pollutants from the home and by bringing in fresh air. https://open.canada.ca/en/open-government-licence-canada
Canadian Urban Data Catalogue Logo
Low-risk alcohol drinking guidelines
Health Canada
Health Canada — 2021-07-07 About alcohol, health effects and risks, a standard drink, how to reduce short-term and long-term health risks, trends in alcohol use among Canadians. https://open.canada.ca/en/open-government-licence-canada
Canadian Urban Data Catalogue Logo
Regulatory Directive: Efficacy Guidelines for Plant Protection Products
Health Canada
Health Canada — 2017-05-18 The aim of the regulation of pest control products is to ensure that pest control products offered for sale and use in Canada are safe to use, effective, and provide a demonstrated benefit or value. Value assessment is an important element of the pre-market evaluation of pest control products. Value assessments, as conducted by the Pest Management Regulatory Agency (PMRA), consist of three components: assessments of efficacy, of economic benefits and competitiveness, and of a pest control product's contribution to sustainability. https://open.canada.ca/en/open-government-licence-canada
Canadian Urban Data Catalogue Logo
Regulating Advertising of Health Products
Health Canada
Health Canada — 2017-05-04 Health Canada sets the standards for health product advertising material in Canada to help advertisers produce messages that are not false, misleading or deceptive. https://open.canada.ca/en/open-government-licence-canada
Canadian Urban Data Catalogue Logo
Health Canada Official Methods for the Testing of Tobacco Products (whole tobacco)
Health Canada
Health Canada — 1999-12-31 The Tobacco Reporting Regulations madeunder the Tobacco and Vaping Products Act incorporate by reference a number of Health Canada official methods that must be followed when dealing with the following: mainstream smoke, sidestream smoke, whole tobacco, sample preparation and toxicity testing. The following tables provide the number of the method, the title and a brief description of the methods for the analysis of the substances found in whole tobacco. https://open.canada.ca/en/open-government-licence-canada
Canadian Urban Data Catalogue Logo
Guidance on summary reports and issue-related analyses for medical devices: Summary reports
Health Canada
Health Canada — 2023-02-22 This guidance document was prepared to help medical device manufacturers understand and comply with the Medical Devices Regulations. Two new requirements in the Regulations were added to ensure the continued monitoring of risks after a product is authorized for sale in Canada. https://open.canada.ca/en/open-government-licence-canada

Map search instructions

1.Turn on the map filter by clicking the “Limit by map area” toggle.
2.Move the map to display your area of interest. Holding the shift key and clicking to draw a box allows for zooming in on a specific area. Search results change as the map moves.
3.Access a record by clicking on an item in the search results or by clicking on a location pin and the linked record title.
Note: Clusters are intended to provide a visual preview of data location. Because there is a maximum of 50 records displayed on the map, they may not be a completely accurate reflection of the total number of search results.

(Author: Health Canada)

Limit by:

Clear all

to